ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007